<code id='B0967F3692'></code><style id='B0967F3692'></style>
    • <acronym id='B0967F3692'></acronym>
      <center id='B0967F3692'><center id='B0967F3692'><tfoot id='B0967F3692'></tfoot></center><abbr id='B0967F3692'><dir id='B0967F3692'><tfoot id='B0967F3692'></tfoot><noframes id='B0967F3692'>

    • <optgroup id='B0967F3692'><strike id='B0967F3692'><sup id='B0967F3692'></sup></strike><code id='B0967F3692'></code></optgroup>
        1. <b id='B0967F3692'><label id='B0967F3692'><select id='B0967F3692'><dt id='B0967F3692'><span id='B0967F3692'></span></dt></select></label></b><u id='B0967F3692'></u>
          <i id='B0967F3692'><strike id='B0967F3692'><tt id='B0967F3692'><pre id='B0967F3692'></pre></tt></strike></i>

          entertainment

          entertainment

          author:fashion    Page View:485
          Lee Klafczynski for STAT

          WASHINGTON — Congress is considering a must-pass pandemic preparedness bill that presents a good opportunity to fix the nation’s current drug shortages problem, which both parties want to do. But most indications are that lawmakers will let that opportunity pass them by.

          Although not new, drug shortages are now a crisis, with an increasing number of reports about cancer doctors having to ration chemotherapies and other drugs.

          advertisement

          Politicians have been well aware of the problem for years. At the request of a large bipartisan group of lawmakers, a task force chaired by the Food and Drug Administration in 2019 reported on the root causes of drug shortages.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more
          FDA’s Peter Marks seems inclined to back Sarepta’s gene therapy
          FDA’s Peter Marks seems inclined to back Sarepta’s gene therapy

          PeterMarks,theFDA'stopregulatorofgenetherapies(right),speakswithSTAT'sAdamFeuersteininSanFrancisco.S

          read more
          As demand for Covid shots wanes, Moderna seeks its next success
          As demand for Covid shots wanes, Moderna seeks its next success

          RubyWallauforSTATModernachairmanNoubarAfeyanexudedstarpowerearlierthismonthashecommandedthespotlight

          read more

          Health and fitness trackers are measuring the wrong things

          BebetoMatthews/APTurnonyourTVoropenawebbrowserthisJanuary,andyou’llbebombardedwithadsforfitnesstrack